Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flows From Operating Activities:    
Net loss $ (7,984) $ (12,236)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 251 246
Subsidiary stock issued to vendor 178 104
Depreciation 169 182
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 724 (600)
Right of use asset 103 86
Accounts payable (1,324) 1,419
Accrued expenses (788) 1,403
Accrued employee benefits (182) (713)
Lease liability (183) (159)
Net Cash Used In Operating Activities (9,036) (10,268)
Cash Flows From Investing Activities:    
Purchases of property and equipment (4) 0
Net Cash Used In Investing Activities (4) 0
Cash Flows From Financing Activities:    
Net Cash From Financing Activities 0 0
Net decrease in cash and cash equivalents (9,040) (10,268)
Cash and cash equivalents at beginning of period 15,045 28,918
Cash and cash equivalents at end of period 6,005 18,650
Noncash Financing Activities:    
Deemed dividends for accretion of Series B Preferred Stock discount 1,315 585
In-kind dividends paid in preferred stock 189 185
Right of use asset from operating lease 0 538
Series B Preferred Stock [Member]    
Noncash Financing Activities:    
Conversion of Series B Preferred Stock $ 2,177 $ 938